(BSNS WIRE) Biocontrol's Diasensor PMA Shell Accepted By FDA
Biocontrol's Diasensor PMA Shell Accepted By FDA
Business Editors
PITTSBURGH--(BUSINESS WIRE)--April 19, 1999--Biocontrol
Technology, Inc. (OTCBB:BICO) announced today, that the premarket
approval application (PMA) Shell for modular review of its Diasensor
2000 noninvasive glucose monitor, submitted in late February, has been
accepted by the Food and Drug Administration (FDA). The Diasensor
2000 is similar to the Diasensor 1000 with enhancements to the
operating software.
With this acceptance and assigned PMA Shell number, Biocontrol
can commence submission of the PMA modules, the first of which is
currently being compiled.
Biocontrol Technology has its corporate offices in Pittsburgh, PA
and is involved in the development and manufacture of biomedical
devices and environmental products. Biocontrol has the exclusive
rights to the research and development and manufacturing of the
Diasensor 2000. Subsidiary Diasensor.com, Inc. also located in
Pittsburgh, PA, owns the parent, marketing and distribution rights to
the sensor.
WEBSITE: www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
--30--tia/ny* jb
CONTACT: Biocontrol Technology, Inc., Pittsburgh
Investors
Diane McQuaide, 412/429-0673
Fax: 412/279-9690
or
Media
Susan Taylor, 412/429-0673
Fax: 412/279-5041
KEYWORD: PENNSYLVANIA
INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY FOODS/BEVERAGES
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
*** end of story ***
|
